PMC:7352545 / 53342-53502 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T213","span":{"begin":20,"end":28},"obj":"Disease"},{"id":"T214","span":{"begin":88,"end":98},"obj":"Disease"},{"id":"T215","span":{"begin":102,"end":110},"obj":"Disease"}],"attributes":[{"id":"A213","pred":"mondo_id","subj":"T213","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A214","pred":"mondo_id","subj":"T214","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A215","pred":"mondo_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"fusion and prevents SARS-CoV-2 entry [95]. nafamostat mesylate inhibits viral entry and thrombosis in COVID-19 patients. Similarly, an FDA-approved mucolytic co"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T74","span":{"begin":43,"end":62},"obj":"Chemical"},{"id":"T75","span":{"begin":148,"end":157},"obj":"Chemical"}],"attributes":[{"id":"A41557","pred":"chebi_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/CHEBI_135466"},{"id":"A14291","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_77034"}],"text":"fusion and prevents SARS-CoV-2 entry [95]. nafamostat mesylate inhibits viral entry and thrombosis in COVID-19 patients. Similarly, an FDA-approved mucolytic co"}

{"project":"2_test","denotations":[{"id":"32604730-32139904-51944058","span":{"begin":38,"end":40},"obj":"32139904"},{"id":"T92226","span":{"begin":38,"end":40},"obj":"32139904"}],"text":"fusion and prevents SARS-CoV-2 entry [95]. nafamostat mesylate inhibits viral entry and thrombosis in COVID-19 patients. Similarly, an FDA-approved mucolytic co"}